申请人:G1 Therapeutics, Inc.
公开号:US10654831B2
公开(公告)日:2020-05-19
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
本发明属于嘧啶类化合物领域,用于治疗涉及细胞异常增殖的疾病,包括但不限于肿瘤和癌症。